HEARTS Package Evaluation Trial in Bangladesh
Evaluation of the WHO HEARTS Hypertension Control Package in the Primary Care Clinics of Bangladesh: A Quasi-experimental Trial
Sponsor: Johns Hopkins University
This NA trial investigates Hypertension and is currently completed. Johns Hopkins University leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
Status: Not Yet Recruiting → Completed
-
Sep 2021 — Aug 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Johns Hopkins University
- National Heart Foundation Hospital and Research Institute, Bangladesh
- National Heart Foundation of Bangladesh
- Non-communicable Disease Control Programme, Directorate General of Health Services, Bangladesh
- Resolve to Save Lives
For direct contact, visit the study record on ClinicalTrials.gov .